I wish it wasnt the case... I've heard PEB refered to as 'NZs most successful university startup...."
Printable View
Which would be wrong. That accolade in modern times belongs probably to AD Instruments, which wasn't held by the Uni for long.
https://en.wikipedia.org/wiki/ADInstruments
NZs best medical research company is/was Glaxo, which started in Bunnythorpe, Wgtn, later to become part of GSK.
History lesson over.
Agree, ADI is a good one. Chatted to Michael McKnight a few times, lives not far from me, by his own account is was many years of hard graft to get where they are.
Molteno is a good one.
I 'thought' Stretchsense were going to be a good modern day example untill they screwed up the deal with their main customer and had to lay off most of the workforce...
https://www.odt.co.nz/business/pacif...ic-new-markets
"Cxbladder to completely replace cytology and be used to complement cystoscopy in the clinical care path for patients presenting to clinicians with haematuria (blood in the urine)," Mr Darling said.
How can you not get excited about the bullishness?
Only problem - it's a blast from the past 7 years ago!
https://www.odt.co.nz/business/pacif...rds-loss-again
For those still looking for inspiration (after being fed a diet of dead rats disguised as 'good' news like great sales growth), there may be hope as '''Canterbury tests are really rocketing,''!!!!!!!!!!
I asked a DHB boss about this statement about 5-6years ago - his response was that it didn't negate the requirement for cystoscopy (as there are other cause of haematuria this would diagnose and treat) and just added test cost to the work up bottom line. Granted it may be useful to "detect" return of bladder ca but it was unclear with this would remove surveillance cystoscopy.
discl - not holding. But held some years ago from 28c to .$1something before I became sadly unconvinced
I approached CDHB, I hold NZ media accreditation, seeking comment on PEB / DD's statement. They have declined to comment at this time. Much like Kaiser, another of PEB's 'partners' don't want to talk about their partnership, full stop. You can read into that what you will...
With PEB, there is only ever one way to read the wildly positive and exuberant pronouncements of this company and its management - their track record and history tell us that.
It's all PR with very little substance.
DD thinks he is a salesman peddling a miracle cure with such a statement - 'Canterbury tests are really rocketing'.
From 50 tests to 200 tests is certainly 'rocketing' but in the overall scheme of things, is like the proverbial pissing against the wind.